Prostaglandins and analogues as agents for lowering intraocular pressure

Details for Australian Patent Application No. 2006311942 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2006311942

PCT Pub. Number WO2007/056087

Priority 60/733,117 03.11.05 US

Filing date 2 November 2006

Wipo publication date 18 May 2007

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/559 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 333/04 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056087 Priority application(s): WO2007/056087

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311944-Automated AC line filter and surge suppression apparatus and method

2006311940-Tennis net singles support stick assembly